Sarepta surges after FDA panel backs Duchenne gene therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/9/2026

1. USO
2. MSFT
3. SPY
4. META
5. COST
6. MU
7. RMR
8. LEVI
9. RXT
10. AAPL

Go back to Sarepta surges after FDA panel backs Duchenne gene therapy
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 20.43 +0.22 (1.09%)
Previous Close $20.21    52 Week High $63.73 
Open $20.39    52 Week Low $8.00 
Day High $20.88    P/E N/A 
Day Low $20.05    EPS $-5.69 
Volume 984,077